These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

503 related articles for article (PubMed ID: 35605679)

  • 21. Targeting Pancreatic Ductal Adenocarcinoma (PDAC).
    Parrasia S; Zoratti M; Szabò I; Biasutto L
    Cell Physiol Biochem; 2021 Jan; 55(1):61-90. PubMed ID: 33508184
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunotherapeutic strategies in pancreatic ductal adenocarcinoma (PDAC): current perspectives and future prospects.
    Nsingwane Z; Candy G; Devar J; Omoshoro-Jones J; Smith M; Nweke E
    Mol Biol Rep; 2020 Aug; 47(8):6269-6280. PubMed ID: 32661873
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pancreatic cancer: Advances and challenges.
    Halbrook CJ; Lyssiotis CA; Pasca di Magliano M; Maitra A
    Cell; 2023 Apr; 186(8):1729-1754. PubMed ID: 37059070
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overcoming chemoresistance by targeting reprogrammed metabolism: the Achilles' heel of pancreatic ductal adenocarcinoma.
    Tuerhong A; Xu J; Shi S; Tan Z; Meng Q; Hua J; Liu J; Zhang B; Wang W; Yu X; Liang C
    Cell Mol Life Sci; 2021 Jul; 78(14):5505-5526. PubMed ID: 34131808
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of hyaluronan in pancreatic cancer biology and therapy: Once again in the spotlight.
    Sato N; Kohi S; Hirata K; Goggins M
    Cancer Sci; 2016 May; 107(5):569-75. PubMed ID: 26918382
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impacting Pancreatic Cancer Therapy in Heterotypic
    Obaid G; Bano S; Mallidi S; Broekgaarden M; Kuriakose J; Silber Z; Bulin AL; Wang Y; Mai Z; Jin W; Simeone D; Hasan T
    Nano Lett; 2019 Nov; 19(11):7573-7587. PubMed ID: 31518145
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An Immunological Glance on Pancreatic Ductal Adenocarcinoma.
    Melzer MK; Arnold F; Stifter K; Zengerling F; Azoitei N; Seufferlein T; Bolenz C; Kleger A
    Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32397303
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting LIF-mediated paracrine interaction for pancreatic cancer therapy and monitoring.
    Shi Y; Gao W; Lytle NK; Huang P; Yuan X; Dann AM; Ridinger-Saison M; DelGiorno KE; Antal CE; Liang G; Atkins AR; Erikson G; Sun H; Meisenhelder J; Terenziani E; Woo G; Fang L; Santisakultarm TP; Manor U; Xu R; Becerra CR; Borazanci E; Von Hoff DD; Grandgenett PM; Hollingsworth MA; Leblanc M; Umetsu SE; Collisson EA; Scadeng M; Lowy AM; Donahue TR; Reya T; Downes M; Evans RM; Wahl GM; Pawson T; Tian R; Hunter T
    Nature; 2019 May; 569(7754):131-135. PubMed ID: 30996350
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Precise Photodynamic Therapy by Midkine Nanobody-Engineered Nanoparticles Remodels the Microenvironment of Pancreatic Ductal Adenocarcinoma and Potentiates the Immunotherapy.
    Qu C; Yuan H; Tian M; Zhang X; Xia P; Shi G; Hou R; Li J; Jiang H; Yang Z; Chen T; Li Z; Wang J; Yuan Y
    ACS Nano; 2024 Feb; 18(5):4019-4037. PubMed ID: 38253029
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Strategies for Increasing Pancreatic Tumor Immunogenicity.
    Johnson BA; Yarchoan M; Lee V; Laheru DA; Jaffee EM
    Clin Cancer Res; 2017 Apr; 23(7):1656-1669. PubMed ID: 28373364
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A tunable delivery platform to provide local chemotherapy for pancreatic ductal adenocarcinoma.
    Indolfi L; Ligorio M; Ting DT; Xega K; Tzafriri AR; Bersani F; Aceto N; Thapar V; Fuchs BC; Deshpande V; Baker AB; Ferrone CR; Haber DA; Langer R; Clark JW; Edelman ER
    Biomaterials; 2016 Jul; 93():71-82. PubMed ID: 27082874
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pancreatic stellate cells and pancreas cancer: current perspectives and future strategies.
    Haqq J; Howells LM; Garcea G; Metcalfe MS; Steward WP; Dennison AR
    Eur J Cancer; 2014 Oct; 50(15):2570-82. PubMed ID: 25091797
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recent Advances in Well-Designed Therapeutic Nanosystems for the Pancreatic Ductal Adenocarcinoma Treatment Dilemma.
    Yang XY; Lu YF; Xu JX; Du YZ; Yu RS
    Molecules; 2023 Feb; 28(3):. PubMed ID: 36771172
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neutrophils in pancreatic ductal adenocarcinoma: bridging preclinical insights to clinical prospects for improved therapeutic strategies.
    Jin Y; Christenson ES; Zheng L; Li K
    Expert Rev Clin Immunol; 2024 Aug; 20(8):945-958. PubMed ID: 38690749
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Galectin-1 in Pancreatic Ductal Adenocarcinoma: Bridging Tumor Biology, Immune Evasion, and Therapeutic Opportunities.
    Bogut A; Stojanovic B; Jovanovic M; Dimitrijevic Stojanovic M; Gajovic N; Stojanovic BS; Balovic G; Jovanovic M; Lazovic A; Mirovic M; Jurisevic M; Jovanovic I; Mladenovic V
    Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958483
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Panoramic tumor microenvironment in pancreatic ductal adenocarcinoma.
    Li X; Hou W; Xiao C; Yang H; Zhao C; Cao D
    Cell Oncol (Dordr); 2024 Oct; 47(5):1561-1578. PubMed ID: 39008192
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exploring the potential of exosomes in diagnosis and drug delivery for pancreatic ductal adenocarcinoma.
    Xu B; Chen Y; Peng M; Zheng JH; Zuo C
    Int J Cancer; 2023 Jan; 152(2):110-122. PubMed ID: 35765844
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Angiogenesis in pancreatic ductal adenocarcinoma: A controversial issue.
    Longo V; Brunetti O; Gnoni A; Cascinu S; Gasparini G; Lorusso V; Ribatti D; Silvestris N
    Oncotarget; 2016 Sep; 7(36):58649-58658. PubMed ID: 27462915
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Paradoxical Web of Pancreatic Cancer Tumor Microenvironment.
    Lafaro KJ; Melstrom LG
    Am J Pathol; 2019 Jan; 189(1):44-57. PubMed ID: 30558722
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A mechanopharmacology approach to overcome chemoresistance in pancreatic cancer.
    Coppola S; Carnevale I; Danen EHJ; Peters GJ; Schmidt T; Assaraf YG; Giovannetti E
    Drug Resist Updat; 2017 Mar; 31():43-51. PubMed ID: 28867243
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.